OneTwo Analytics

Listen to our CMO Per-Ola Carlsson share insights about his research in type 1 diabetes!

In light of World Diabetes Day, we want to highlight the importance of continued diabetes research. We asked some of our colleagues at OneTwo Analytics, who have a personal connection to diabetes, to share their experiences and what a cure would mean to them. ➡️ Swipe to read their stories. More funding is essential to bring us closer to a cure. Every contribution, no matter how small, can help create a future where diabetes is no longer a daily challenge. Together, let’s make a difference. Donate today: - Barndiabetesfonden Swish your support to 900 05 97. Your donation will fund critical research on type 1 diabetes. https://lnkd.in/ddhRdbF - Breakthrough T1D Donate today at: https://lnkd.in/d8-iXQYr https://lnkd.in/drun48-k #worlddiabetesday

What an incredible event hosted by eHealthVentures and beMedTech on Tuesday! The day was packed with insightful presentations and engaging discussions, sparking exciting possibilities for future collaborations. With so much innovation happening in the field of diabetes, we are eager to see what the future holds. A big thank you to the other innovative companies for their impressive presentations. And a special highlight: our CSO, Daniel Espes, delivered an outstanding pitch, which was honored by both the jury and the audience, winning the pitch competition!

Meet us in Brussels! On October 15th, our co-founder and CSO Daniel Espes will be attending the eHealthVentures & beMedTech event: "Rethinking Diabetes Care: From Innovation to New Care Models". Don't miss the opportunity to connect with Daniel, learn more about OneTwo Analytics, and explore how we're driving innovation in diabetes management. 📧 daniel.espes@onetwo-analytics.com #diabetes #diabetesmanagment #medtech

Meet the Team Behind OneTwo Analytics! We’re thrilled to introduce Loke, our adorable office dog! Loke is dedicated to spreading joy and providing cuddles to our team while enjoying the occasional nap. Loke has his own experience with diabetes, as his owner, Linnea, lives with type 1 diabetes and is also an important member of OneTwo Analytics. "I’ve started to learn when my mom's blood sugar gets low. She becomes a bit shaky and confused, and that’s when I know something’s off. My dream is to one day become a real diabetic alert dog, so I can help her even better!" In his spare time, Loke enjoys going for long walks, lying on the porch watching the sunset, and chewing on bones.

We’re live at the EASD Conference in Madrid! OneTwo Analytics is thrilled to be on the ground at the #EASD conference. Come visit us at the Dexcom Partner Experience Stand and explore our cutting-edge solutions: ▶ PRIO: A population management and need-based risk stratification tool ▶ INSIGHTS: Our AI/ML healthcare platform that analyzes glucose data from CGM sensors ▶ OneTwo Diabetes: A CE-marked app that seamlessly integrates with CGM sensors for automatic analysis. Don’t miss us at the Diabetes Center Berne Innovation Zone in the Exhibition, where Steven Pusterla will be presenting at 14:30 on Wednesday. If you’re attending, connect with Steven Pusterla and Lars Cederblad on LinkedIn or arrange a meeting via their calendars: Steven's Calendar: https://lnkd.in/dGsSBE2h Lars's Calendar: https://lnkd.in/dkb38jjV Looking forward to insightful conversations and future collaborations! 

We are thrilled to announce the latest publication in BMJ Journals by the OneTwo Analytics team, where we share the fundamentals behind the development of our solution, PRIO! Meet our CEO and co-author, Lars Cederblad, at European Association for the Study of Diabetes e.V. (EASD) to learn more about PRIO and how it enables population management and stratification in diabetes clinics. Check out the full article here: https://lnkd.in/d8DRD3ex #Diabetes #Innovation #MedTech #Healthcare

We are thrilled to announce the latest publication in BMJ Journals by the OneTwo Analytics team, where we share the fundamentals behind the development of our solution, PRIO! Meet our CEO and co-author, Lars Cederblad, at European Association for the Study of Diabetes e.V. (EASD) to learn more about PRIO and how it enables population management and stratification in diabetes clinics. Check out the full article here: https://lnkd.in/d8DRD3ex #Diabetes #Innovation #MedTech #Healthcare

Will we be seeing you at the EASD conference in Madrid, 9-13 September? OneTwo Analytics is excited to participate in the European Association for the Study of Diabetes (EASD) conference in Madrid, Spain! Find us at the Dexcom Partner Experience Stand to learn more about our innovative solutions: PRIO: A population management and need-based risk stratification tool. INSIGHTS: Our AI/ML healthcare platform that analyzes glucose data from CGM sensors. OneTwo Diabetes: CE-marked app seamlessly integrating with CGM sensors for automatic analyses. We’ll also be featured in the Diabetes Center Berne EASD Innovation Zone, where you can discover more about how we’re transforming diabetes care. Our team members Steven Pusterla and Lars Cederblad will be attending the conference. Contact us to arrange a meeting: Steven's Calendar: https://lnkd.in/dR3SCazw Lars's Calendar: https://lnkd.in/dGy88yYZ Looking forward to seeing you there!

Exciting News! We are thrilled to announce that OneTwo Analytics PRIO and the OneTwo Diabetes app have achieved Class 1 exempt status from the FDA in the United States. This pivotal achievement allows us to introduce our groundbreaking solutions to the US market, empowering healthcare providers and patients to enhance their capabilities and improve outcomes. PRIO has been established as an advanced population management and risk stratification tool. It offers improved efficiencies and personalized scheduling recommendations tailored to individual patient needs. By evaluating essential factors such as glucose control and other healthcare markers, PRIO effectively stack ranks the population, determining the most effective type of appointment—whether in-person or virtual—and its optimal duration. OneTwo Diabetes is a CE-marked patient application that complements the deep analysis and guidance provided by our INSIGHTS platform. Our solutions integrate seamlessly with CGM sensors for automatic analyses. Designed to enhance clinic visits, it provides daily support and employs sophisticated algorithms to identify meals and potential causes of glucose fluctuations, delivering personalized insights for enhanced glucose management. For more information about our innovative solutions, please visit our website at www.onetwo-analytics.com. To view our FDA listing, please visit the FDA’s Establishment Registration & Device Listing here: https://lnkd.in/dfRbZxcM Stay tuned for more exciting news and updates as we continue to innovate and transform the landscape of diabetes care! #FDA #medtech #diabetes